Patent ID: 9114140
Filing Date: 2015-08-25
Classification: A61K,A61P

Abstract:
1. A method for initiating an improvement of human mood and inducing an observable enhancement of cognitive functions in a living human subject, said method comprising the steps of: obtaining a non-prescription blended formulation suitable for oral ingestion by a living human subject, said blended formulation being a controlled nootropic admixture consisting of five different kinds of essential nootropic active ingredients, each of which is able to pass the blood-brain barrier in-vivo, said controlled nootropic admixture having wherein the ratio of all individual nootropic neurotransmitter agonists to all individual nootropic adenosine antagonists is proportionally not less than 5:1, and wherein the neurotransmitter replenishment balance for the admixture of essential active agents mathematically is zero (“0”) in value, and wherein there is a complete absence of any other kind of nootropic agonist or antagonist; orally administering said blended formulation to a living human subject in a predetermined quantity sufficient to initiate an improvement of human mood and induce an observable enhancement of cognitive functions in a living human subject; allowing at least a minimal time period after ingestion for said orally administered quantity of blended formulation to become assimilated by and to act within the body of said living human subject; periodically monitoring the human subject for objective indications of a positive mental state and an observable enhancement of cognitive functions; and determining from said objective indications that a more positive mental state exists and an observable enhancement of cognitive functions has occurred in the living human subject.